The subcutaneous implantable cardioverter-defibrillator in review

NJ Kamp, SM Al-Khatib - American heart journal, 2019 - Elsevier
The subcutaneous implantable cardioverter defibrillator (S-ICD) is a completely
extrathoracic device that has recently been FDA approved for the prevention of sudden …

Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Systematic Review and Meta‐Analysis of Randomized Trials and Propensity Score–Matched …

KY Fong, CJR Ng, Y Wang, C Yeo… - Journal of the American …, 2022 - Am Heart Assoc
Background Subcutaneous implantable cardioverter‐defibrillators (S‐ICDs) have been of
great interest as an alternative to transvenous implantable cardioverter‐defibrillators (TV …

Implantation technique and optimal subcutaneous defibrillator chest position: a PRAETORIAN score-based study

P Francia, M Biffi, C Adduci, L Ottaviano… - EP …, 2020 - academic.oup.com
Aims The traditional technique for subcutaneous implantable cardioverter-defibrillator (S-
ICD) implantation involves three incisions and a subcutaneous pocket. Recently, a two …

[HTML][HTML] Understanding outcomes with the EMBLEM S-ICD in primary prevention patients with low EF study (UNTOUCHED): clinical characteristics and perioperative …

LV Boersma, MF El-Chami, MG Bongiorni, MC Burke… - Heart Rhythm, 2019 - Elsevier
Background The subcutaneous implantable cardioverter-defibrillator (S-ICD) has shown
favorable outcomes in large registries with broad inclusion criteria. The cohorts reported had …

[HTML][HTML] Long-term performance of a novel communicating antitachycardia pacing–enabled leadless pacemaker and subcutaneous implantable cardioverter …

KTN Breeman, B Swackhamer, AJ Brisben… - Heart Rhythm, 2022 - Elsevier
Background Subcutaneous implantable cardioverter-defibrillators (S-ICDs) and leadless
pacemakers (LPs) are intended to diminish transvenous lead–related complications …

Anesthesia for subcutaneous implantable cardioverter‐defibrillator implantation: perspectives from the clinical experience of a US panel of physicians

MK Essandoh, GE Mark, JD Aasbo… - Pacing and Clinical …, 2018 - Wiley Online Library
Background and objective Worldwide adoption of the subcutaneous implantable
cardioverter‐defibrillator (S‐ICD) for preventing sudden cardiac death continues to increase …

Impact of body mass index on safety and efficacy of the subcutaneous implantable cardioverter-defibrillator

DS Frankel, MC Burke, DJ Callans, TM Stivland… - JACC: Clinical …, 2018 - jacc.org
Objectives: This study determined whether obesity increased the risk of failed shocks and
complications among subcutaneous implantable cardioverter-defibrillator (S-ICD) recipients …

Implantation of the subcutaneous implantable cardioverter–defibrillator with truncal plane blocks

MA Miller, HV Bhatt, M Weiner, TF Brouwer… - Heart Rhythm, 2018 - Elsevier
Operative anesthetic requirements and perioperative discomfort are barriers to wide
adoption of the subcutaneous implantable cardioverter–defibrillator (SICD) system. The …

Intermuscular technique for implantation of the subcutaneous implantable defibrillator: a propensity-matched case–control study

GL Botto, M Ziacchi, G Nigro, A D'Onofrio… - Europace, 2023 - academic.oup.com
Aims A previous randomized study demonstrated that the subcutaneous implantable
cardioverter defibrillator (S-ICD) was noninferior to transvenous ICD with respect to device …

Oversensing issues leading to device extraction: when subcutaneous implantable cardioverter-defibrillator reached a dead-end

A Noel, S Ploux, S Bulliard, M Strik, A Haeberlin… - Heart Rhythm, 2020 - Elsevier
Background Subcutaneous implantable cardioverter-defibrillator (S-ICD) implantations are
rapidly expanding. However, the subcutaneous detection and interpretation of cardiac …